These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 29182737)

  • 21. Clinicians' perspectives on diagnosing polycystic ovary syndrome in Australia: a qualitative study.
    Copp T; Muscat DM; Hersch J; McCaffery KJ; Doust J; Mol BW; Dokras A; Jansen J
    Hum Reprod; 2020 Mar; 35(3):660-668. PubMed ID: 32101283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome.
    Kim JJ; Chae SJ; Choi YM; Hwang KR; Song SH; Yoon SH; Kim SM; Ku SY; Kim SH; Kim JG; Moon SY
    Hum Reprod; 2013 May; 28(5):1354-60. PubMed ID: 23477907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sexual and relational satisfaction in couples where the woman has polycystic ovary syndrome: a dyadic analysis.
    De Frène V; Verhofstadt L; Loeys T; Stuyver I; Buysse A; De Sutter P
    Hum Reprod; 2015 Mar; 30(3):625-31. PubMed ID: 25534460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of childhood adiposity with menstrual irregularity and polycystic ovary syndrome in adulthood: the Childhood Determinants of Adult Health Study and the Bogalusa Heart Study.
    He Y; Tian J; Blizzard L; Oddy WH; Dwyer T; Bazzano LA; Hickey M; Harville EW; Venn AJ
    Hum Reprod; 2020 May; 35(5):1185-1198. PubMed ID: 32344436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
    Yildiz BO; Bozdag G; Yapici Z; Esinler I; Yarali H
    Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility and acceptability of a proposed trial of acupuncture as an adjunct to lifestyle interventions for weight loss in Polycystic Ovary Syndrome: a qualitative study.
    Ee C; Smith C; Costello M; MacMillan F; Moran L; Baylock B; Teede H
    BMC Complement Altern Med; 2018 Nov; 18(1):298. PubMed ID: 30409195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.
    Dewailly D; Alebić MŠ; Duhamel A; Stojanović N
    Hum Reprod; 2014 Nov; 29(11):2536-43. PubMed ID: 25267785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polycystic ovary syndrome susceptibility single nucleotide polymorphisms in women with a single PCOS clinical feature.
    Cui L; Li G; Zhong W; Bian Y; Su S; Sheng Y; Shi Y; Wei D; Zhang W; Zhao H; Chen ZJ
    Hum Reprod; 2015 Mar; 30(3):732-6. PubMed ID: 25586784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of polycystic ovary syndrome is associated with longer anogenital distance in adult Mediterranean women.
    Sánchez-Ferrer ML; Mendiola J; Hernández-Peñalver AI; Corbalán-Biyang S; Carmona-Barnosi A; Prieto-Sánchez MT; Nieto A; Torres-Cantero AM
    Hum Reprod; 2017 Nov; 32(11):2315-2323. PubMed ID: 29025054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A genetic risk score is associated with polycystic ovary syndrome-related traits.
    Lee H; Oh JY; Sung YA; Chung HW
    Hum Reprod; 2016 Jan; 31(1):209-15. PubMed ID: 26573528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
    Cooney LG; Lee I; Sammel MD; Dokras A
    Hum Reprod; 2017 May; 32(5):1075-1091. PubMed ID: 28333286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and replication of prediction models for ovulation, pregnancy and live birth in infertile women with polycystic ovary syndrome.
    Kuang H; Jin S; Hansen KR; Diamond MP; Coutifaris C; Casson P; Christman G; Alvero R; Huang H; Bates GW; Usadi R; Lucidi S; Baker V; Santoro N; Eisenberg E; Legro RS; Zhang H;
    Hum Reprod; 2015 Sep; 30(9):2222-33. PubMed ID: 26202922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternal and neonatal outcomes in pregnant women with PCOS: comparison of different diagnostic definitions.
    Kollmann M; Klaritsch P; Martins WP; Guenther F; Schneider V; Herzog SA; Craciunas L; Lang U; Obermayer-Pietsch B; Lerchbaum E; Raine-Fenning N
    Hum Reprod; 2015 Oct; 30(10):2396-403. PubMed ID: 26223675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychometric properties of the Iranian version of modified polycystic ovary syndrome health-related quality-of-life questionnaire.
    Bazarganipour F; Ziaei S; Montazeri A; Faghihzadeh S; Frozanfard F
    Hum Reprod; 2012 Sep; 27(9):2729-36. PubMed ID: 22740491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of dietary and physical activity behaviors in women with and without polycystic ovary syndrome: a systematic review and meta-analysis of 39 471 women.
    Kazemi M; Kim JY; Wan C; Xiong JD; Michalak J; Xavier IB; Ganga K; Tay CT; Grieger JA; Parry SA; Moran LJ; Lujan ME
    Hum Reprod Update; 2022 Nov; 28(6):910-955. PubMed ID: 35639552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Women's perceptions of polycystic ovary syndrome following participation in a clinical research study: implications for knowledge, feelings, and daily health practices.
    Colwell K; Lujan ME; Lawson KL; Pierson RA; Chizen DR
    J Obstet Gynaecol Can; 2010 May; 32(5):453-459. PubMed ID: 20500954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure.
    Wu Y; Zhong G; Chen S; Zheng C; Liao D; Xie M
    Hum Reprod; 2017 Apr; 32(4):937-943. PubMed ID: 28333243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contraception use and pregnancy outcomes in women with polycystic ovary syndrome: data from the Australian Longitudinal Study on Women's Health.
    Joham AE; Boyle JA; Ranasinha S; Zoungas S; Teede HJ
    Hum Reprod; 2014 Apr; 29(4):802-8. PubMed ID: 24549213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.